Hospital Pharmacy presents a new feature to keep pharmacists abreast of new publications in the medical/pharmacy literature. Articles of interest will be abstracted monthly regarding a broad scope of topics.
Get full access to this article
View all access options for this article.
References
1.
DursunB., EdelsteinC.L.Acute renal failure. Am J Kidney Dis.2005; 45(3): 614–618.
2.
LaRosaJ.C., GrundyS.M., WatersD.D., ShearC.Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med.2005; Epub ahead of print. Available at: http://content.nejm.org/content/abstract/NEJMoa050461v1.
3.
Cdiav-CitrinO., ShectamanS., OrnoyS., ArnonJ.Safety of haloperidol and penfluirdol in pregnancy: A multi-center, prospective, controlled study. J Clin Psychiatry.2005; 66: 317–322.
4.
HesterE.K., ThrowerM.R.Current options in the management of olanzapine associated weight gain. Ann Pharmacother.2005; 39: 302–310.
5.
BeckE., SieberW.J., TrejoR.Management of cluster headache. Am Family Physician.2005; 71: 717–724, 778.
6.
Ramos-CasalsM., TzioulasA.G., FontJ.Primary Sjogren's syndrome: New clinical and therapeutic concepts. Ann Rheum Dis.2005; 64: 347–354.
7.
LiebowitzM.R., GelenbergA.J., MunjackD.Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Arch Gen Psychiatry.2005; 62: 190–198.
8.
Fonesca-AtenM., MessinaA.F., JafriH.S., SanchezP.J.Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant. Pediatrics.2005; 115: 804–809.
9.
CravatiE.Reconsidering the safety of over the counter decongestants. Ann Emerg Med.2005; 45(2): 217–218.
10.
VillerJ., Perez-MendezL., Aguirre-JaimeA., KaemarekR.M.Why are physicians so skeptical about positive randomized controlled critical trials in critical care medicine?Intensive Care Medicine.2005; 31: 196–204.
SchleinitzM.D., HeidenreichP.A.A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: Clopidogrel and aspirin versus aspirin alone. Ann Intern Med.2005; 142: 251–259.
13.
McIntyreR.S., KonarskiJ.Z., GrigoriadisS., FanN.C.Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship. CMAJ.2005; 172: 57–59.
14.
RidkerP.M., CookN.R., LeeI.M., GordonD.A randomized trial of low dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med.2005; 352: Epub ahead of print. Available at: http://content.nejm.org/cgi/content/abstract/NEJMoa050613v1.
15.
KyleS., ChandlerD., GriffithsC.E.M., HelliwellP.Guideline for anti-TNF-alpha therapy in psoriatic arthritis. Rheumatology.2005; 44: 396–397.
16.
Van RiemsdijkM.M., SturkenboomMCJM, PepplinkhuizenL., StrickerB.H.Mefloquine increases the risk of serious psychiatric events during travel abroad: A nationwide case control study in the Netherlands. J Clin Psychiatry.2005; 66: 199–204.
17.
KobakK.A., TaylorL.H., WarnerG., FuttererR.St. John's wort versus placebo in social phobia. J Clin Psychopharmacol.2005; 25(1): 51–57.
